Lupin receives USFDA approval for triamcinolone acetonide cream
Lupin has received final approval from USFDA to market its generic version of Mylan’s triamcinolone acetonide cream used for treatment of skin disease. The approval […]
lupin
Lupin receives CDSCO approval for Acotiamide drug
Lupin has received Central Drugs Standard Control Organisation (CDSCO) approval for Acotiamide 100 mg tablets used for the treatment of indigestion. The drug Acotiamide is […]
Lupin receives USFDA approval for Omeprazole delayed-release capsules 40 mg
Lupin has received final approval from USFDA for its Omeprazole delayed-release capsules 40 mg which is market equivalent of AstraZeneca Prilosec delayed-release capsules 40mg. The […]
Lupin acquires Gavis and Novel Labs in US
Lupin Limited has signed an agreement to acquire privately held Gavis Pharmaceuticals LLC and Novel Laboratories Inc (Gavis) for a value of USD 880 million. […]
Lupin acquires Zao Biocom of Russia
Lupin today has acquired Zao Biocom, a generic pharma company in Russia to make its foray into the Russian market. It is estimated that Russia […]